Research team (IMAGE)
Caption
Led by Professor Anskar Leung Yu-hung (centre), HKUMed’s Department of Medicine, School of Clinical Medicine, the research team has identified PLK4 as a novel therapeutic target for acute myeloid leukaemia carrying the TP53 mutation.
Credit
The University of Hong Kong
Usage Restrictions
N/A
License
Original content